The U.S. Food and Drug Administration (FDA) has approved prademagene zamikeracel (Zevaskyn) for the treatment of blistering ...

Stem cells are transforming modern medicine by accelerating wound healing, repairing tissue, and enhancing skin aesthetics, according to Professor Dr. M. Al-Fareed Zafar, Principal of Ameer Uddin ...

Patients with severe dystrophic epidermolysis bullosa, or EB, have skin so fragile, the slightest touch can lead to ...

Microbion Phase 2 study shows favorable safety and early efficacy data, with 46.7% of patients treated achieving complete wound closure. A ...

GRAPEVINE, TX, UNITED STATES, May 2, 2025 /EINPresswire.com/ -- A comprehensive, multicenter retrospective study showed positive findings evaluating the safety and efficacy of using mechanical ...

Even compared to chimpanzees, our closest relatives, our wounds are slow to recover – but it could be the outcome of us ...

The FDA has approved Zevaskyn (prademagene zamikeracel) for the treatment of recessive dystrophic epidermolysis bullosa, a rare genetic skin disorder.

A new exhibit at the Cleveland Botanical Garden uses art to explore the healing power of nature and pathways it can provide ...

A team of evolutionary scientists, dermatologists and wildlife specialists affiliated with several institutions in Japan, ...

Researchers have found that wounds heal three times more slowly in humans than in other primates and rodents, suggesting we ...

Abeona has won FDA approval for Zevaskyn, setting up a commercial challenge to Krystal Biotech in the rare skin disease ...